BREAKING: MORE SCANDAL VICAR, Ashington Innovations – this gets worse and worse
By Tom Winnifrith | Thursday 24 August 2023
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
I have already clearly demonstrated that the proposed £135 million RTO of technically insolvent Cell Therapy ( aka Celixir) by Ashington Innovations (ASHI) is a complete rum and coke HERE. I have been discussing that with the FCA today. If it approves the prospectus it will be one of its biggest blunders in years. But now it gets worse.
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism
Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.